The revision of China‘s Foreign Investment Negative List has reached a pivotal milestone. The current applicable national version remains the 2024 Edition (Negative List for Foreign Investment Access), which took effect on November 1, 2024 and reduced special restriction measures from 31 to 29[reference:0][reference:1]. The most defining achievement of this edition: all manufacturing sector access restrictions have been completely eliminated, achieving full“zero limit” liberalization[reference:2][reference:3]. As of 2026, this“clean slate”for manufacturing is fully enforced with no remaining foreign equity caps or joint venture requirements in any manufacturing sub‑sector. For foreign investors seeking to establish wholly foreign-owned enterprises (WFOEs) in China, the manufacturing sector now presents a completely open field — from automotive components and industrial machinery to advanced electronics and high‑end equipment — all accessible without ownership restrictions. Building on this foundation, China has signaled the next wave of opening, with a clear policy focus shifting toward service sector liberalization.
1. Current Legal Framework: 2024 Edition Negative List (29 Items)
China‘s foreign investment access system is governed by the Foreign Investment Negative List, officially titled the Special Administrative Measures for Foreign Investment Access (Negative List). Two parallel lists apply in practice: the National Negative List (currently the 2024 Edition, effective November 1, 2024) and the Free Trade Zone (FTZ) Negative List, which contains fewer restrictions and serves as a testing ground for further liberalization (Shanghai FTZ list currently has 17 measures)[reference:4]. The 2024 national list reduced special restriction measures from 31 to 29, with two key deletions: (1) the requirement that “publication printing must be controlled by Chinese parties” and (2) the prohibition on investment in certain traditional Chinese medicine processing technologies[reference:5][reference:6]. The Foreign Investment Negative List applies uniformly to all foreign investors, regardless of whether they invest through a WFOE, a joint venture, or other legal structures.
As of 2026, industry discussions suggest a further reduction in the Negative List to approximately 27 items nationwide[reference:7]. A 2026 edition is anticipated (potentially 40 items in certain interpretations, though the authoritative count remains the 2024 edition figures)[reference:8][reference:9]. However, even before the next formal edition is published, a series of service sector “pilot opening” measures have already been implemented, effectively expanding foreign investment access ahead of the formal Negative List revision. The key distinction for foreign investors is that the Negative List governs market access approval, while the broader cross‑border service trade negative list (跨境服务贸易负面清单) applies to service transactions across borders. For 2026, the cross‑border service trade negative list has also been expanded to include new opening measures[reference:10][reference:11]. Outside the Negative List, foreign investors enjoy the same treatment as domestic investors (national treatment) under the Foreign Investment Law.
2. Manufacturing Sector: Full “Zero Limit” Access Achieved
China has completely eliminated all foreign ownership restrictions in the manufacturing sector. The 2024 edition removed the last two remaining restrictions in the manufacturing negative list: “publication printing must be controlled by Chinese parties” (allowing wholly foreign-owned printing enterprises in China) and “prohibition on investment in certain traditional Chinese medicine processing technologies”[reference:12]. As a result of these deletions, the manufacturing field has achieved a “clear zero” of access restrictions, with no remaining national equity ratio requirements, joint venture mandates, or prohibitions on wholly foreign-owned enterprises in any manufacturing sub‑sector[reference:13]. In practice, this means that foreign investors can now establish 100% foreign‑owned factories, assembly plants, and production facilities across all manufacturing industries — from basic industrial components to high‑precision machinery, automotive parts, electronics, pharmaceuticals, and advanced materials — without the need to identify a Chinese joint venture partner.
China has publicly confirmed that the manufacturing sector is now “completely opened,” allowing foreign-owned enterprises to operate across the full range of permitted manufacturing activities[reference:14]. This “complete opening” policy is notable for its direct correlation to business scope registration: foreign investors can now list a full range of manufacturing business activities in their Articles of Association without seeking special approvals or joint venture structures. For foreign-owned enterprises that qualify as “small and low‑profit enterprises” (small and micro FIEs), the 2026 tax filing period remains open for the 2025 tax year under the extended preferential policies, including the 5% effective corporate income tax rate and the 50% reduction of six local taxes. Manufacturers should verify eligibility during the annual CIT reconciliation (which runs through May 31, 2026).
3. Value‑Added Telecom Services: Wholly Foreign-Owned Entry
A historic liberalization is underway in China‘s telecommunications sector, moving from equity caps to wholly foreign-owned entry. Under pilot programs (effective April 2026 in designated regions), the following value-added telecom services have removed foreign equity caps entirely:
- Internet Data Centers (IDC)
- Content Delivery Networks (CDN)
- Internet Access Services
- Online Data Processing and Transaction Processing (EDI)
- Information Services (ICP – App Store category only, excluding prohibited fields such as internet news, online publishing, online audio‑visual, internet culture operations) – capped at 50% foreign equity nationwide but fully open in certain regions[reference:15]
Qualified foreign investors may now establish wholly foreign-owned enterprises (100% equity) for these businesses, a significant relaxation from the previous 50% cap on foreign shareholding in value-added telecom services[reference:16][reference:17]. In practice, this means a foreign cloud services provider can now establish a wholly owned IDC in China; a foreign content delivery company can operate a wholly owned CDN network; and a foreign e‑commerce platform can maintain full equity control of its EDI operations. The Ministry of Industry and Information Technology (MIIT) has already issued operational pilot approvals to the first batch of foreign enterprises in 2025, with subsequent batches expected throughout 2026[reference:18]. Pilot regions currently include Beijing, Shanghai, Shenzhen, Hainan, and other designated zones. However, key service categories remain restricted: internet news information services, online publishing, online audio‑visual programming, and internet culture operations are prohibited for foreign investment[reference:19].
4. Biotechnology Sector: New Pilot Opening
Biotechnology has emerged as a priority sector for foreign investment liberalization. Pilot programs have been introduced to allow wholly foreign-owned enterprises in biotechnology R&D, bio‑pharmaceutical manufacturing, gene technology applications, and clinical research and development under specified conditions[reference:20][reference:21]. These pilot programs apply in designated regions including Beijing, Shanghai, Guangdong (Greater Bay Area), and Hainan Free Trade Port. For biotechnology companies, the practical implication is that foreign investors can now establish wholly owned R&D centers, manufacturing facilities, and clinical research organizations in China without mandatory joint venture partners — significantly reducing the complexity of intellectual property protection and profit repatriation. The policy is part of a broader State Council directive on “expanding pilot openings in telecommunications, biotechnology, and wholly foreign-owned hospitals,” and the cross‑border service trade negative list has been refined to align with these new access rules[reference:22][reference:23]. However, China retains separate regulations for specific fields such as stem cell research, certain gene therapies, and medical data management, which may impose additional licensing or reporting requirements beyond the basic negative list access framework. Entities engaged in human genetic resource activities must also comply with the Biosecurity Law and relevant human genetic resource regulations.
5. Wholly Foreign-Owned Hospitals: Medical Sector Opening
After years of restrictive joint venture requirements, China has opened the door to wholly foreign-owned hospitals. Pilot programs in designated regions allow foreign investors to establish wholly-owned general hospitals, specialty hospitals, and rehabilitation centers under specified conditions[reference:24][reference:25]. Key requirements: hospitals must comply with China‘s medical institution standards (including facility, staffing, and equipment requirements); operational licenses are subject to approval by provincial health commissions; medical insurance coverage eligibility is not automatic and must be separately negotiated; and certain infectious disease treatment capabilities may be mandated depending on hospital category. Pilot regions currently include Beijing, Shanghai, Guangzhou, Shenzhen, Hainan Free Trade Port, and other approved zones. For foreign healthcare providers, this represents the most significant opening in the medical sector since China’s WTO accession, allowing full ownership control and profit repatriation without a Chinese joint venture partner. The policy is part of a coordinated service sector liberalization effort, aligning with openings in telecommunications and biotechnology[reference:26].
6. QFLP Pilot Expansion – New Channels for Foreign Capital
In parallel with Negative List liberalization, the Qualified Foreign Limited Partner (QFLP) pilot program has expanded, allowing foreign investors to convert offshore capital into RMB for investment in domestic non‑publicly traded enterprises[reference:27]. As of 2026, QFLP pilots are active in Shanghai, Shenzhen, Beijing, Hainan, Shaanxi, and over 10 other regions, with pilot scopes expanding to include new investment directions such as infrastructure and green projects[reference:28]. For foreign investors, QFLP provides an important supplementary channel to direct foreign investment, particularly for private equity, venture capital, and real estate investments outside the manufacturing sector. The QFLP expansion is coordinated with the opening of biotechnology and telecommunications sectors, ensuring that foreign capital has multiple pathways to enter newly liberalized industries[reference:29].
7. Pilot Regions vs. Nationwide Access: A Two‑Track System
Foreign investors must understand China‘s two‑track foreign investment access system:
- Nationwide access (governed by the National Negative List): Manufacturing is fully open. Services such as most value-added telecom, biotechnology, and wholly foreign-owned hospitals are not yet fully opened nationwide — certain categories require pilot region presence.
- Pilot region access (FTZs, Hainan Free Trade Port, designated service opening zones): Enhanced openings apply, including fully‑open value-added telecom services (no equity caps), wholly foreign-owned biotechnology enterprises, wholly foreign-owned hospitals, and relaxed foreign executive visa policies. The Shanghai FTZ Negative List has only 17 measures[reference:30], significantly fewer than the national list.
Foreign investors with operations that rely on services sector openings should consider establishing their main business presence in a pilot region, while using nationwide access for manufacturing activities or registered office functions. Services that are not covered by pilot openings remain subject to existing national restrictions (foreign equity caps, joint venture requirements). For investors uncertain about their business scope classification, a negative list pre‑check is available through the “Shanghai Enterprise Registration Online (International Version)” platform and other regional portals, which generate an Access Pre‑clearance Report when the industry code is entered[reference:31].
8. Practical Compliance Roadmap for Foreign Investors in 2026
To successfully establish a foreign‑owned enterprise under the new Negative List framework, follow this 5‑step roadmap:
- Verify business scope legality (Immediate): Review your intended business activities against the National Negative List (2024 Edition) and the cross‑border service trade negative list. Use the online pre‑clearance system for a preliminary check. If the intended activity falls under a “pilot opening,” confirm that your proposed location is within a designated pilot region (telecom services, wholly foreign-owned hospitals, biotechnology). For restricted activities requiring approvals, obtain the necessary licenses before submitting the business registration application.
- Select appropriate legal structure (Month 1): For manufacturing businesses, a wholly foreign-owned enterprise (WFOE) is now permissible across all sub‑sectors. For value-added telecom, biotechnology, and healthcare services, determine whether to establish in a pilot region or apply under existing restrictions.
- Prepare and translate registration documents (Month 1-2): All documents submitted to SAMR must be in simplified Chinese or accompanied by certified translations. Work with an agent experienced in 2025-2026 registration forms and procedures.
- Use the unified online filing portal (Month 2-3): Name pre‑approval, business license application, and Articles of Association filing can now be submitted simultaneously through the national online portal. The review period is typically 5‑10 working days, with electronic license delivery.
- Complete post‑licensing formalities (Month 3): After license issuance: company chop registration (legal, financial, contract seals), VAT registration with the tax bureau (within 30 days), corporate bank account opening (capital account for foreign currency remittance and RMB account for operations), social insurance and housing fund registration (within 30 days), and, if applicable, industry‑specific licenses (e.g., ICP license, medical institution license).
Summary: China‘s Negative List for foreign investment has achieved full manufacturing liberalization (2024 Edition, 29 restrictions), while shifting the focus of further opening to service sectors through pilot programs. Key opening priorities for 2026 include value‑added telecommunications (pilot regions allowing wholly foreign-owned IDC, CDN, internet access, and EDI services), biotechnology R&D and manufacturing (pilot regions), wholly foreign-owned hospitals (pilot regions), and expanded QFLP pilots for foreign capital channels. The National Negative List remains the governing framework for nationwide access, while pilot regions (including Shanghai, Beijing, Shenzhen, Hainan, and Greater Bay Area) offer enhanced openings across these service sectors. Foreign investors should verify business scope legality, establish in pilot regions when appropriate, and follow the streamlined online registration process. With manufacturing fully open and services opening underway, China‘s foreign investment environment is more accessible than at any time in the past decade.